These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 3730164

  • 21. Performance and biocompatibility of a new hemodialysis membrane.
    von Herrath D, Dati F, Pelzer H, Hartenstein K, Kutschera D, Schaefer K.
    Blood Purif; 1986; 4(1-3):151-8. PubMed ID: 3637111
    [Abstract] [Full Text] [Related]

  • 22. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S.
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [Abstract] [Full Text] [Related]

  • 23. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE, Cheung AK, Ward DM, Henderson LW.
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [Abstract] [Full Text] [Related]

  • 24. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
    Rousseau Y, Carreno MP, Poignet JL, Kazatchkine MD, Haeffner-Cavaillon N.
    Biomaterials; 1999 Oct; 20(20):1959-67. PubMed ID: 10514074
    [Abstract] [Full Text] [Related]

  • 25. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK, Chenoweth DE, Otsuka D, Henderson LW.
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [Abstract] [Full Text] [Related]

  • 26. Effect of hemodialysis on leukocyte adhesion receptor expression.
    Kaupke CJ, Zhang J, Cesario T, Yousefi S, Akeel N, Vaziri ND.
    Am J Kidney Dis; 1996 Feb; 27(2):244-52. PubMed ID: 8659501
    [Abstract] [Full Text] [Related]

  • 27. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM, Freitas LA, Alves VC, Garção MF, Rosa MA, Marques AA.
    Am J Nephrol; 2001 Feb; 21(4):264-73. PubMed ID: 11509797
    [Abstract] [Full Text] [Related]

  • 28. Research on dialyzers with improved biocompatibility.
    van der Steen A.
    Clin Nephrol; 1986 Feb; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [Abstract] [Full Text] [Related]

  • 29. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC, Ringoir SM.
    Blood Purif; 1990 Feb; 8(1):32-44. PubMed ID: 2198890
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J.
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [Abstract] [Full Text] [Related]

  • 31. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation.
    Marchant A, Tielemans C, Husson C, Gastaldello K, Schurmans T, De Groote D, Duchow J, Vanherweghem L, Goldman M.
    Nephrol Dial Transplant; 1996 Apr; 11(4):657-62. PubMed ID: 8671854
    [Abstract] [Full Text] [Related]

  • 32. In vivo analysis of the Lundia 5 (PRO 5) and Lundia 3 (PRO 3) dialyzers with Gambrane polycarbonate membranes.
    Miller JH, Shinaberger JH, Henderson LW, Gardner PW.
    Blood Purif; 1986 Apr; 4(1-3):63-73. PubMed ID: 3730163
    [Abstract] [Full Text] [Related]

  • 33. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Apr; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 34. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A, Castillo D, Castro M, Pérez R, Rios A, Jaraba M, Aljama P.
    Nephrol Dial Transplant; 1991 Apr; 6 Suppl 2():55-8. PubMed ID: 1866069
    [Abstract] [Full Text] [Related]

  • 35. In vivo induction of interleukin-1 during hemodialysis.
    Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bacle F, Delons S, Kazatchkine MD.
    Kidney Int; 1989 May; 35(5):1212-8. PubMed ID: 2788763
    [Abstract] [Full Text] [Related]

  • 36. Neutrophil behavior during hemodialysis. Role of membrane contact.
    Neveceral P, Markert M, Wauters JP.
    ASAIO Trans; 1988 May; 34(3):564-7. PubMed ID: 2848563
    [Abstract] [Full Text] [Related]

  • 37. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K, Kobira S, Tomoyoshi T, Nishimura N.
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [Abstract] [Full Text] [Related]

  • 38. Different in vitro generation of C3d by cuprammonium and polycarbonate capillary hemodialyzers.
    Notohamiprodjo M, Andrassy K, Bommer J, Kirschfink M, Rother U, Ritz E.
    Nephron; 1986 Sep; 43(4):254-7. PubMed ID: 3488513
    [Abstract] [Full Text] [Related]

  • 39. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM, Breillatt J, Lazarus JM, Port FK.
    N Engl J Med; 1984 Oct 04; 311(14):878-82. PubMed ID: 6332276
    [Abstract] [Full Text] [Related]

  • 40. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K, Würzner R, Kronenberg F, Oppermann M, König P.
    Kidney Int; 1998 Apr 04; 53(4):1044-51. PubMed ID: 9551416
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.